Illumina | ILMN - Debt

Stock Price
142.54
Daily Change
-0.70 -0.49%
Monthly
7.40%
Yearly
70.46%
Q2 Forecast
139.67

Illumina reported $2.55B in Debt for its fiscal quarter ending in December of 2025.





Debt Change Date
Agilent USD 3.35B 55M Sep/2025
Bio Techne USD 200M 60M Mar/2026
Bio-Rad Laboratories USD 1.39B 9.2M Dec/2025
Boston Scientific USD 11.44B 610M Dec/2025
Bruker USD 2.04B 34.4M Dec/2025
Charles River Laboratories USD 2.57B 58.23M Dec/2025
Danaher USD 18.48B 66M Mar/2026
Dentsply International USD 2.33B 137M Mar/2026
Edwards Lifesciences USD 600M 105.4M Mar/2026
Illumina USD 2.55B 23M Dec/2025
Intuitive Surgical USD 0 0 Mar/2025
IQVIA Holdings USD 15.83B 109M Mar/2026
Laboratory Of America USD 6.53B 3.9M Dec/2025
Mettler Toledo International USD 2.15B 57.69M Dec/2025
Myriad Genetics USD 59.3M 19.7M Mar/2025
OraSure Technologies USD 782K 465K Jun/2024
Pacific Biosciences Of California USD 892.24M 653K Dec/2023
Quest Diagnostics USD 6.41B 179M Mar/2026
Quidel USD 2.83B 9.9M Dec/2025
Repligen USD 546.58M 4.37M Mar/2026
Revvity USD 3.4B 29.2M Dec/2025
Roche Holding CHF 33.03B 1.41B Jun/2025
Standard Biotools USD 27.39M 1.23M Sep/2025
Thermo Fisher Scientific USD 39.39B 3.7B Dec/2025
Waters USD 1.49B 4.92M Dec/2025